Funding Sarcoma Cancer Research

Natalie Wolf

A major component of Rein in Sarcoma's mission is to fund research directed toward developing new treatments and finding cures for sarcoma cancers. Since our inception in 2001 RIS has funded nearly $2 million to sarcoma research projects, primarily at the University of Minnesota, with an expansion to the Mayo Clinic, Children's Hospitals and Clinics of Minnesota and SARC in 2017. These research dollars in turn have leveraged over $7 million in public and private funding to date.